Pfizer PFE Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.7B-9.3% | —— | $3.55B-20.6% | $2.93B+6,000% | $2.97B-4.8% | ||
| $1.61B-0.3% | $1.69B-5.8% | $1.66B-5.3% | $1.63B-6.1% | $1.62B-6.8% | ||
| $272M+60.0% | $225M+27.1% | $201M-26.6% | $203M-1.5% | $170M-22.7% | ||
| $2.62B+12.0% | $5.35B-20.4% | $4.6B-31.4% | $0+100% | $2.34B+114% | ||
| $436M-22.7% | $845M-7.9% | $602M-7.5% | $618M-3.0% | $564M-19.9% | ||
| $785M-76.0% | -$6.15B— | -$2.43B— | $3.95B-14.1% | $3.27B+89.0% | ||
| -$2.86B+45.4% | $0+100% | -$2.48B+46.6% | -$3.2B-30.0% | -$5.23B-6.0% | ||
| $563M+50.1% | —— | —— | $213M— | $375M+118% | ||
| $2.18B+23.0% | $4.5B-22.4% | $4B-34.0% | —— | $1.77B+359% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Pfizer generate?
- Pfizer (PFE) generated $12.6B in operating cash flow over the trailing twelve months.
- What is Pfizer's free cash flow?
- After $2.5B of capital expenditures, Pfizer's free cash flow was $12.5B over the trailing twelve months, up 26.6% year over year.
- Where does Pfizer's cash flow data come from?
- Every line is extracted from Pfizer's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
